Calcium and vitamin D supplementation in postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 11, 2013, Pages

  Aloia, John F ^a   Dhaliwal, Ruban ^a   Shieh, Albert ^a   Mikhail, Mageda ^a   Islam, Shahidul ^a   Yeh, James K ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; COLECALCIFEROL; PARATHYROID HORMONE; PLACEBO; PROCOLLAGEN; PROCOLLAGEN TYPE I N TERMINAL PROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE TURNOVER; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CONGENITAL DISORDER; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EVENING DOSAGE; FAMILIAL DISEASE; FEMALE; GASTROINTESTINAL DISEASE; GENETIC DISORDER; HEART DISEASE; HORMONE RESPONSE; HUMAN; IMMUNOPATHOLOGY; INFECTION; INJURY; INTOXICATION; MEDIASTINUM DISEASE; MENTAL DISEASE; METABOLIC DISORDER; MORNING DOSAGE; MUSCULOSKELETAL DISEASE; NEOPLASM; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SKIN DISEASE; SOFT TISSUE DISEASE; THORAX DISEASE; VASCULAR DISEASE;

AGED; BONE AND BONES; BONE REMODELING; CALCIUM; CALCIUM, DIETARY; CHOLECALCIFEROL; COLLAGEN TYPE I; DIETARY SUPPLEMENTS; FEMALE; FRACTURES, BONE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; OSTEOMALACIA; OSTEOPOROSIS; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PEPTIDES; PLACEBOS; POSTMENOPAUSE; PROCOLLAGEN; VITAMINS;

EID: 84887482091     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2121     Document Type: Article

References (25)

1. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D, WA, DC:The National Academies Press. 2011;XXX.
2. Aloia JF. The 2011 report on dietary reference intake for vitamin D: where dowego from here? J Clin Endocrinol Metab. 2011;96:2987- 2996.
3. Ross AC, Manson JE, Abrams SA, et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96: 53-58.
4. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011; 96: 1911-1930.
5. Rosen CJ, Abrams SA, Aloia JF, et al. IOM committee members respond to Endocrine Society vitaminDguideline. J Clin Endocrinol Metab. 2012;97: 1146-1152.
6. Chung M, Balk EM, Brendel M, et al. Vitamin D and Calcium: A Systematic Review of Health Outcomes. Evidence Report No. 183. (Prepared by the Tufts Evidence-based Practice Center under Contract No. HHSA 290-2007-10055-I.) AHRQ Publication No. 09- E015. Rockville, MD: Agency for Healthcare Research and Quality; 2009.
7. Aloia J, Bojadzievski T, Yusupov E, et al. The relative influence of calcium intake and vitaminDstatus on serum parathyroid hormone and bone turnover biomarkers in a double-blind, placebo-controlled parallel group, longitudinal factorial design. J Clin Endocrinol Metab. 2010;95: 3216-3224.
8. Orum O, Hansen M, Jensen CH, et al. Procollagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval, and hypovitaminosis D induced hyperparathyroidism. Bone. 1996;19: 157-163.
9. Rosen HN, Moses AC, Garber J, et al. Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int. 2000;66: 100-103.
10. Carter GD, Carter CR, Gunter E, et al. Measurement of vitamin D metabolites: an international perspective on methodology and clinical interpretation. J Steroid Biochem Mol Biol. 2004;89-90: 467-471.
11. Millen AE, Midthune D, Thompson FE, Kipnis V, Subar AF. The National Cancer Institute diet history questionnaire: validation of pyramid food servings. Am J Epidemiol. 2006;163: 279-288.
12. Little R, Rubin D. Statistical Analysis With Missing Data. New York, NY: Wiley; 2002.
13. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
14. Sai AJ, Walters RW, Fang X, Gallagher JC. Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab. 2011;96:E436-E446.
15. Grimnes G, Joakimsen R, Figenschau Y, Torjesen PA, Almås B, Jorde R. The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass-a randomized controlled 1-year trial. Osteoporos Int. 2012;23: 201-211.
16. Aloia JF, Talwar SA, Pollack S, Yeh J.Arandomized controlled trial of vitamin D3 supplementation in African American women. Arch Intern Med. 2005;165: 1618-1623.
17. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA. 2005;294: 2336-2341.
18. Ganji V, Zhang X, Tangpricha V. Serum 25-hydroxyvitaminDconcentrations and prevalence estimates of hypovitaminosis D in the U.S. population based on assay-adjusted data. J Nutr. 2012;142: 498-507.
19. Wallace RB, Wactawski-Wende J, O'Sullivan MJ, et al. Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr. 2011;94: 270-277.
20. Snellman G, Melhus H, Gedeborg R, et al.2010. Determining vitamin D status: a comparison between commercially available assays. PloS One. 2010;5:e11555.
21. Aloia JF, Arunabh-Talwar S, Pollack S, Yeh JK. The remodeling transient and the calcium economy. Osteoporos Int. 2008;19:1001- 1009.
22. Heaney RP, Recker RR, Saville PD. Calcium balance and calcium requirements in middle-aged women. Am J Clin Nutr. 1977;30: 1603-1611.
23. Heaney RP. The bone-remodeling transient: implications for the interpretation of clinical studies of bone mass change. J Bone Miner Res. 1994;9: 1515-1523.
24. Bolland MJ, Grey A, Gamble GD, Reid IR. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr. 2011;94: 1144-1149.
25. Kimball SM, Ursell MR, O'Connor P, Vieth R. Safety of vitaminD3 in adults with multiple sclerosis.AmJ Clin Nutr. 2007;86: 645-651.